| Utestående aktier | 10,799,417 shares |
| Insideraktier | 5 420 161 shares |
| Insynsägande | 50,19 % |
| Totalt antal insynspersoner | 13 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
1575 out of 11219Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Lantern Pharma Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Arunkumar Asaithambi
10% Owner -
|
883 920 | 883 920 | |
|
Biological Mimetics Inc
10% Owner -
|
2 088 000 | 2 088 000 | |
|
BIOS Fund I QP, LP
10% Owner -
|
329 904 | 114 272 | |
| Bhatia Kishor G. | 17 400 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Vijay Chandru | 3 200 | ||
|
Fletcher Aaron G.L.
10% Owner -
|
114 272 | 114 272 | |
|
Green Park & Golf Ventures II, LLC
10% Owner -
|
131 697 | 131 697 | |
| D Jeffrey Keyser Director - [D] | 0 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Kreis Leslie W.
10% Owner -
|
114 272 | 114 272 | |
| Margrave David R. | 26 100 | ||
| Franklyn G Prendergast | 3 200 | ||
| Panna Sharma | 76 628 | ||
|
Silberstein David S.
Director, 10% Owner -
[D]
|
2 088 000 | 2 088 000 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i LTRN / Lantern Pharma Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
| Handelsdatum | Insider | Rapporterade aktier |
Rapporterat pris |
Justerade aktier |
Justerat pris |
Kostnadsbasis | Dagar til Max |
Pris vid Max |
Maximal vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-11 | KEYSER D JEFFREY | 10 000 | 15,0000 | 10 000 | 15,0000 | 150 000 | 279 | 21.92 | 69 200 | 46,13 |
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i LTRN / Lantern Pharma Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-13 | 2025-06-13 | 4 | Fletcher Aaron G.L. by Bios Fund II, LP | LTRN | Common Stock | I | 3,0900 | −4 354 | −13 | 114 272 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,0900 | −14 218 | −44 | 373 178 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,0900 | −1 903 | −6 | 49 957 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,0900 | −12 319 | −38 | 323 335 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,0900 | −7 206 | −22 | 189 117 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,0900 | −4 354 | −13 | 114 272 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,0900 | −14 218 | −44 | 373 178 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,0900 | −1 903 | −6 | 49 957 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,0900 | −12 319 | −38 | 323 335 | ||||
| 2025-06-13 | 2025-06-13 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,0900 | −7 206 | −22 | 189 117 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 3,3800 | −6 601 | −22 | 118 626 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,3800 | −21 557 | −73 | 387 396 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,3800 | −2 886 | −10 | 51 860 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,3800 | −18 678 | −63 | 335 654 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,3800 | −10 925 | −37 | 196 323 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 3,4000 | −103 | −0 | 125 227 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,4000 | −338 | −1 | 408 953 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,4000 | −45 | −0 | 54 746 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,4000 | −293 | −1 | 354 332 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,4000 | −171 | −1 | 207 248 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 3,4000 | −2 | −0 | 125 330 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,4000 | −5 | −0 | 409 291 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,4000 | −5 | −0 | 409 291 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,4000 | −1 | −0 | 54 791 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,4000 | −3 | −0 | 207 419 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,3800 | −6 601 | −22 | 118 626 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,3800 | −21 557 | −73 | 387 396 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,3800 | −2 886 | −10 | 51 860 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,3800 | −18 678 | −63 | 335 654 | ||||
| 2025-06-13 | 2025-06-12 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,3800 | −10 925 | −37 | 196 323 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,4000 | −103 | −0 | 125 227 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,4000 | −338 | −1 | 408 953 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,4000 | −45 | −0 | 54 746 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,4000 | −293 | −1 | 354 332 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,4000 | −171 | −1 | 207 248 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,4000 | −2 | −0 | 125 330 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,4000 | −5 | −0 | 409 291 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,4000 | −5 | −0 | 409 291 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,4000 | −1 | −0 | 54 791 | ||||
| 2025-06-13 | 2025-06-10 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,4000 | −3 | −0 | 207 419 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 3,0300 | −2 199 | −7 | 125 332 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,0300 | −7 180 | −22 | 409 296 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,0300 | −961 | −3 | 54 792 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,0300 | −6 221 | −19 | 354 630 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,0300 | −3 639 | −11 | 207 422 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 2,8700 | −1 632 | −5 | 127 531 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 2,8700 | −5 332 | −15 | 416 476 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 2,8700 | −714 | −2 | 55 753 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 2,8700 | −4 620 | −13 | 360 851 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 2,8700 | −2 702 | −8 | 211 061 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 3,0500 | −2 290 | −7 | 129 163 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,0500 | −7 478 | −23 | 421 808 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,0500 | −1 000 | −3 | 56 467 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,0500 | −6 479 | −20 | 365 471 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,0500 | −3 790 | −12 | 213 763 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,0300 | −2 199 | −7 | 125 332 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,0300 | −7 180 | −22 | 409 296 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,0300 | −961 | −3 | 54 792 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,0300 | −6 221 | −19 | 354 630 | ||||
| 2025-05-29 | 2025-05-29 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,0300 | −3 639 | −11 | 207 422 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 2,8700 | −1 632 | −5 | 127 531 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 2,8700 | −5 332 | −15 | 416 476 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 2,8700 | −714 | −2 | 55 753 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 2,8700 | −4 620 | −13 | 360 851 | ||||
| 2025-05-29 | 2025-05-28 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 2,8700 | −2 702 | −8 | 211 061 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,0500 | −2 290 | −7 | 129 163 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,0500 | −7 478 | −23 | 421 808 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,0500 | −1 000 | −3 | 56 467 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,0500 | −6 479 | −20 | 365 471 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,0500 | −3 790 | −12 | 213 763 | ||||
| 2024-07-26 | 2024-07-24 | 4 | KEYSER D JEFFREY | LTRN | Common stock | D | 3,1300 | 3 832 | 12 | 0 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 6,3300 | −4 253 | −27 | 131 453 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 6,3300 | −13 888 | −88 | 429 286 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 6,3300 | −1 859 | −12 | 57 467 | ||||
| 2024-05-28 | 2024-05-23 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 6,2500 | −2 126 | −13 | 135 706 | ||||
| 2024-05-28 | 2024-05-23 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 6,2500 | −6 944 | −43 | 443 174 | ||||
| 2024-05-28 | 2024-05-23 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 6,2500 | −930 | −6 | 59 326 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 6,3300 | −4 253 | −27 | 131 453 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 6,3300 | −13 888 | −88 | 429 286 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 6,3300 | −1 859 | −12 | 57 467 | ||||
| 2024-05-28 | 2024-05-23 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 6,2500 | −2 126 | −13 | 135 706 | ||||
| 2024-05-28 | 2024-05-23 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 6,2500 | −6 944 | −43 | 443 174 | ||||
| 2024-05-28 | 2024-05-23 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 6,2500 | −930 | −6 | 59 326 | ||||
| 2024-02-29 | 2024-02-29 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 4,8700 | −4 185 | −20 | 137 832 | ||||
| 2024-02-29 | 2024-02-29 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,8700 | −13 686 | −67 | 450 118 | ||||
| 2024-02-29 | 2024-02-29 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,8700 | −1 832 | −9 | 60 256 | ||||
| 2024-02-29 | 2024-02-28 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 4,8500 | −15 780 | −77 | 142 017 | ||||
| 2024-02-29 | 2024-02-28 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,8500 | −51 608 | −250 | 463 804 | ||||
| 2024-02-29 | 2024-02-28 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,8500 | −6 909 | −34 | 62 088 | ||||
| 2024-02-29 | 2024-02-27 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 4,4000 | −10 620 | −47 | 157 797 | ||||
| 2024-02-29 | 2024-02-27 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,4000 | −34 731 | −153 | 515 412 | ||||
| 2024-02-29 | 2024-02-27 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,4000 | −4 649 | −20 | 68 997 | ||||
| 2024-02-29 | 2024-02-29 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 4,8700 | −4 185 | −20 | 137 832 | ||||
| 2024-02-29 | 2024-02-29 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,8700 | −13 686 | −67 | 450 118 | ||||
| 2024-02-29 | 2024-02-29 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,8700 | −1 832 | −9 | 60 256 | ||||
| 2024-02-29 | 2024-02-28 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 4,8500 | −15 780 | −77 | 142 017 | ||||
| 2024-02-29 | 2024-02-28 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,8500 | −51 608 | −250 | 463 804 | ||||
| 2024-02-29 | 2024-02-28 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,8500 | −6 909 | −34 | 62 088 | ||||
| 2024-02-29 | 2024-02-27 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 4,4000 | −10 620 | −47 | 157 797 | ||||
| 2024-02-29 | 2024-02-27 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,4000 | −34 731 | −153 | 515 412 | ||||
| 2024-02-29 | 2024-02-27 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,4000 | −4 649 | −20 | 68 997 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 4,2000 | −12 521 | −53 | 168 417 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 3,1300 | 16 801 | 53 | 180 938 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,2000 | −40 893 | −172 | 550 143 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,1300 | 54 873 | 172 | 591 036 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,2000 | −5 475 | −23 | 73 646 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,1300 | 7 347 | 23 | 79 121 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 4,2000 | −12 521 | −53 | 168 417 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 3,1300 | 16 801 | 53 | 180 938 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,2000 | −40 893 | −172 | 550 143 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 3,1300 | 54 873 | 172 | 591 036 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,2000 | −5 475 | −23 | 73 646 | ||||
| 2024-01-19 | 2024-01-17 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 3,1300 | 7 347 | 23 | 79 121 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 3,4400 | −91 708 | −315 | 371 950 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,4400 | −53 640 | −185 | 217 553 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 3,4400 | −91 708 | −315 | 371 950 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 3,4400 | −53 640 | −185 | 217 553 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 4,4000 | −40 586 | −179 | 164 137 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,4000 | −132 575 | −583 | 536 163 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,4000 | −17 748 | −78 | 71 774 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 4,4000 | −100 380 | −442 | 463 658 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 4,4000 | −58 711 | −258 | 271 193 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 4,4000 | −40 586 | −179 | 164 137 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 4,4000 | −132 575 | −583 | 536 163 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 4,4000 | −17 748 | −78 | 71 774 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 4,4000 | −100 380 | −442 | 463 658 | ||||
| 2022-11-09 | 2022-11-08 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 4,4000 | −58 711 | −258 | 271 193 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Fletcher Aaron G.L. By BP Directors, LP | LTRN | Common Stock | I | 5,2000 | −1 275 | −7 | 26 093 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Fletcher Aaron G.L. By BP Directors, LP | LTRN | Common Stock | I | 1,0300 | 6 438 | 7 | 27 328 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Fletcher Aaron G.L. By BP Directors, LP | LTRN | Common Stock | I | 5,2000 | −5 170 | −27 | 20 930 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Fletcher Aaron G.L. By BP Directors, LP | LTRN | Common Stock | I | 1,0300 | 26 100 | 27 | 26 100 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Kreis Leslie W. By BP Directors,LP | LTRN | Common Stock | I | 5,2000 | −1 275 | −7 | 26 093 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Kreis Leslie W. By BP Directors,LP | LTRN | Common Stock | I | 1,0300 | 6 438 | 7 | 27 328 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Kreis Leslie W. By BP Directors,LP | LTRN | Common Stock | I | 5,2000 | −5 170 | −27 | 20 930 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Kreis Leslie W. By BP Directors,LP | LTRN | Common Stock | I | 1,0300 | 26 100 | 27 | 26 100 | ||||
| 2022-03-21 | 2022-03-17 | 4 | Kreis Leslie W. Bios Fund I QP, LP | LTRN | Series A Warrants | I | −35 347 | 0 | ||||||
| 2022-03-21 | 2022-03-17 | 4 | Kreis Leslie W. Bios Fund I, LP | LTRN | Series A Warrants | I | −60 432 | 0 | ||||||
| 2022-03-21 | 2022-03-17 | 4 | Kreis Leslie W. Bios Fund I QP, LP | LTRN | Common Stock | I | 110 636,1100 | 35 347 | 3 910 655 | 329 904 | ||||
| 2022-03-21 | 2022-03-17 | 4 | Kreis Leslie W. Bios Fund I, LP | LTRN | Common Stock | I | 189 152,1600 | 60 432 | 11 430 843 | 564 038 | ||||
| 2021-11-08 | 2021-11-04 | 4 | Kreis Leslie W. By BP Directors, LP | LTRN | Stock Option | I | 10,32 | 3 200 | 3 200 | |||||
| 2021-11-08 | 2021-11-04 | 4 | Silberstein David S. | LTRN | Stock Option (Right to Buy) | D | 10,32 | 3 200 | 3 200 | |||||
| 2021-11-08 | 2021-11-04 | 4 | Chandru Vijay | LTRN | Stock Option (Right to Buy) | D | 10,32 | 3 200 | 3 200 | |||||
| 2021-11-08 | 2021-11-04 | 4 | PRENDERGAST FRANKLYN G | LTRN | Stock Option (Right to Buy) | D | 10,32 | 3 200 | 3 200 | |||||
| 2021-11-08 | 2021-11-04 | 4 | KEYSER D JEFFREY | LTRN | Stock Option (Right to Buy) | D | 10,32 | 3 200 | 3 200 | |||||
| 2021-11-02 | 2021-10-29 | 4 | Margrave David R. | LTRN | Stock Option (Right to Buy) | D | 10,21 | 26 100 | 26 100 | |||||
| 2021-11-02 | 2021-10-29 | 4 | Bhatia Kishor G. | LTRN | Stock Option (Right to Buy) | D | 10,21 | 17 400 | 17 400 | |||||
| 2020-06-17 | 2020-06-16 | 4 | Green Park & Golf Ventures II, LLC | LTRN | Series A Preferred Stock, par value $0.01 | I | −75 688 | 0 | ||||||
| 2020-06-17 | 2020-06-15 | 4 | Green Park & Golf Ventures II, LLC | LTRN | Series A Preferred Stock, par value $0.01 | I | −168 164 | 0 | ||||||
| 2020-06-17 | 2020-06-15 | 4 | Green Park & Golf Ventures II, LLC | LTRN | Series A Preferred Stock, par value $0.01 | I | −23 871 | 0 | ||||||
| 2020-06-17 | 2020-06-15 | 4 | Green Park & Golf Ventures II, LLC | LTRN | Common Stock, par value $0.0001 | I | 131 697 | 131 697 | ||||||
| 2020-06-17 | 2020-06-15 | 4 | Green Park & Golf Ventures II, LLC | LTRN | Common Stock, par value $0.0001 | I | 292 605 | 292 605 | ||||||
| 2020-06-17 | 2020-06-15 | 4 | Green Park & Golf Ventures II, LLC | LTRN | Common Stock, par value $0.0001 | I | 41 535 | 211 291 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By affiliate | LTRN | Stock Options | I | 15,00 | 9 135 | 9 135 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Series A Preferred Stock | I | −35 181 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Series A Preferred Stock | I | −262 806 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Series A Preferred Stock | I | −80 454 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Series A Preferred Stock | I | −169 286 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Series A Preferred Stock | I | −289 429 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund II NT, LP | LTRN | Common Stock | I | 61 214 | 89 522 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund II QP, LP | LTRN | Common Stock | I | 457 282 | 668 738 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP | LTRN | Common Stock | I | 139 989 | 204 723 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund I QP, LP | LTRN | Common Stock | I | 294 557 | 294 557 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP | LTRN | Common Stock | I | 503 606 | 503 606 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. | LTRN | Stock Options | D | 15,00 | 9 135 | 9 135 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Series A Preferred Stock | I | −35 181 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Series A Preferred Stock | I | −262 806 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Series A Preferred Stock | I | −80 454 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Series A Preferred Stock | I | −169 286 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Series A Preferred Stock | I | −289 429 | 0 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund II NT, LP | LTRN | Common Stock | I | 61 214 | 89 522 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund II QP, LP | LTRN | Common Stock | I | 457 282 | 668 738 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund II, LP | LTRN | Common Stock | I | 139 989 | 204 723 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund I QP, LP | LTRN | Common Stock | I | 294 557 | 294 557 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Kreis Leslie W. By Bios Fund I, LP | LTRN | Common Stock | I | 503 606 | 503 606 | ||||||
| 2020-06-15 | 2020-06-15 | 4 | PRENDERGAST FRANKLYN G | LTRN | Stock Option | D | 15,00 | 9 135 | 9 135 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Bhatia Kishor G. | LTRN | Stock Option | D | 15,00 | 52 200 | 52 200 | |||||
| 2020-06-15 | 2020-06-15 | 4 | SHARMA PANNA | LTRN | Stock Option | D | 15,00 | 76 628 | 76 628 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Chandru Vijay | LTRN | Stock Option | D | 15,00 | 9 135 | 9 135 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Margrave David R. | LTRN | Stock Option | D | 15,00 | 78 300 | 78 300 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Silberstein David S. | LTRN | Stock Option | D | 15,00 | 9 135 | 9 135 | |||||
| 2020-06-15 | 2020-06-11 | 4 | KEYSER D JEFFREY | LTRN | Common Stock | D | 15,0000 | 10 000 | 150 | 10 000 | ||||
| 2020-06-15 | 2020-06-15 | 4 | KEYSER D JEFFREY | LTRN | Stock Option | D | 15,00 | 9 135 | 9 135 | |||||
| 2020-06-15 | 2020-06-15 | 4 | KEYSER D JEFFREY | LTRN | Series A Preferred Stock | D | −18 349 | 0 | ||||||
| 2020-06-15 | 2020-06-15 | 4 | KEYSER D JEFFREY | LTRN | Common Stock | D | 31 927 | 41 927 | ||||||
| 2020-06-10 | 3 | Asaithambi Arunkumar | LTRN | Common Stock | D | 883 920 | ||||||||
| 2020-06-10 | 3 | Asaithambi Arunkumar | LTRN | Common Stock | D | 883 920 | ||||||||
| 2020-06-10 | 3 | Asaithambi Arunkumar | LTRN | Common Stock | D | 883 920 | ||||||||
| 2020-06-10 | 3 | BIOLOGICAL MIMETICS INC | LTRN | Common Stock | D | 2 088 000 | ||||||||
| 2020-06-10 | 3 | BIOLOGICAL MIMETICS INC | LTRN | Common Stock | D | 2 088 000 | ||||||||
| 2020-06-10 | 3 | BIOLOGICAL MIMETICS INC | LTRN | Common Stock | D | 2 088 000 | ||||||||
| 2020-06-10 | 3 | Silberstein David S. See Explanation of Responses. | LTRN | Common Stock | I | 2 088 000 | ||||||||
| 2020-06-10 | 3 | Silberstein David S. See Explanation of Responses. | LTRN | Common Stock | I | 2 088 000 | ||||||||
| 2020-06-10 | 3 | Silberstein David S. See Explanation of Responses. | LTRN | Common Stock | I | 2 088 000 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | Soderstrom Carl D | LTRN | Common Stock, par value $0.0001 | I | 339 512 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BP Directors, LP By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II NT, LP | LTRN | Common Stock | I | 332 806 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II QP, LP | LTRN | Common Stock | I | 515 954 | ||||||||
| 2020-06-10 | 3 | BIOS Advisors GP, LLC By Bios Fund II, LP | LTRN | Common Stock | I | 369 232 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
